Facts & figures
As of: January, 2019
1) primarily from public funds (EU, Federal Government, State Government); according to Campus Buch: total funding since 1992, incl. BIMSB
2) primarily from own ressources, since 2001
3) primarily from own ressources
4) since 2009
5) since 2006
6) since 2002
| Research Institutions of Campus Berlin-Buch Employees (total) |
2,151 |
|
| of these: | ||
| Max Delbrück Center for Molecular Medicine (MDC): | 1,646 | |
| Leibniz Institute of Molecular Pharmacology (FMP): | 303 | |
| Klinische Forschung Charité Campus Buch: | 202 | |
| Budget and third-party grants (total)1 | EUR 192 million | |
| Max Delbrück Center for Molecular Medicine (MDC): | EUR 147 million | |
| Leibniz Institute of Molecular Pharmacology (FMP): | EUR 29 million | |
| Klinische Forschung Charité Campus Buch: | EUR 16 million | |
| BiotechPark Berlin-Buch | ||
| Number of companies: | 62 | |
| Employees: | 800 | |
| Annual revenue: Percentage of third-party grants: 3,1% |
EUR 220 million |
|
| Hospitals & Patient-Care Institutions | ||
| Employees (total): of these: |
3,564 | |
| HELIOS Klinikum Berlin-Buch: | 2,700 | |
| Evangelische Lungenklinik: | 325 | |
| Immanuel Krankenhaus Berlin, Standort Buch (Rheumaklinik): | 89 |
|
| Patient-care institutions: | 450 | |
| Number of patient beds: | 1,267 | |
| Patients per year (inpatient and outpatient): | 220,519 | |
| Total investment volume of these: |
EUR 1.451 billion | |
| Infrastructure Campus Berlin-Buch1 | EUR 624 million | |
| HELIOS Klinikum Berlin-Buch² | EUR 336 million | |
| Evangelische Lungenklinik3 | EUR 49 million | |
| Immanuel Krankenhaus Berlin, Standort Buch (Rheumaklinik)1 | EUR 39 million |
|
| LudwigPark 3 | EUR 45 million | |
| Allées des Châteaux 3 | EUR 23 million | |
| Widerker Vermögensverwaltung (Schlosspark-Passage) 3 | EUR 29 million |
|
| Ludwig Hoffmann Quartier | EUR 152 million |
|
| Housing construction associations (HOWOGE 3,4, EWG 3,5, WBG 3,6 Hau+S 3,5 ) | EUR 154 million |
News Buch Berlin
A double-pronged attack on malignant B cells
Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In “Molecular Therapy,” a team led by Armin Rehm presents an improved immunotherapy that ...
more ...A new opportunity for Berlin
The Einstein Center for Early Disease Interception has been funded with six million euros. In an interview, Nikolaus Rajewsky and Leif Erik Sander, both spokespeople of the center, explain why new tec...
more ...A spin-off targeting neuromuscular disorders
A team led by Mina Gouti has developed a stem cell-based model that enables researchers to test new drugs to treat neuromuscular diseases and to refine existing therapies. The project, called NMJCare,...
more ...Events Buch Berlin
25.02.2026, 10:00
JUGEND FORSCHT – 61. Regional-Wettbewerb: Maximale Perspektive
Für die 61. Wettbewerbsrunde von Jugend forscht haben sich mehr als 11 000 Jungforscherinnen und Jungforscher angemeldet - die Beteiligung ist deutlich gestiegen.
more ...18.03.2026, 08:30
vocatium Berlin focus 2026: Fachmesse für Ausbildung+Studium
Entdecke berufliche Möglichkeiten, informiere dich und sprich mit Expert:innen über Einstieg, Voraussetzungen und Bewerbung.
more ...20.03.2026, 08:45
Einladung: UniStem Day für Berliner Schülerinnen und Schüler aus Biokursen
Das German Stem Cell Network (GSCN) lädt die an Biologie interessierten Berliner Schülerinnen und Schüler (Biologie-Leistungskurse und Grundkurse) mit ihren Lehrkräften herzlich zum UniStem Day – zum ...
more ...
